BSA degradation under acidic conditions: A model for protein instability during release from PLGA delivery systems
dc.contributor.author | Estey, Tia | en_US |
dc.contributor.author | Kang, Jichao | en_US |
dc.contributor.author | Schwendeman, Steven P. | en_US |
dc.contributor.author | Carpenter, John F. | en_US |
dc.date.accessioned | 2007-07-11T18:14:27Z | |
dc.date.available | 2007-07-11T18:14:27Z | |
dc.date.issued | 2006-07 | en_US |
dc.identifier.citation | Estey, Tia; Kang, Jichao; Schwendeman, Steven P.; Carpenter, John F. (2006). "BSA degradation under acidic conditions: A model for protein instability during release from PLGA delivery systems." Journal of Pharmaceutical Sciences 95(7): 1626-1639. <http://hdl.handle.net/2027.42/55225> | en_US |
dc.identifier.issn | 0022-3549 | en_US |
dc.identifier.issn | 1520-6017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/55225 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16729268&dopt=citation | en_US |
dc.description.abstract | Acidification of the internal poly(lactide- co -glycolide) (PLGA) microenvironment is considered one of the major protein stresses during controlled release from such delivery systems. A model protein, bovine serum albumin (BSA), was incubated at 37°C for 28 days to simulate the environment within the aqueous pores of PLGA during the release phase and to determine how acidic microclimate conditions affect BSA stability. Size-exclusion high performance liquid chromatography (SE-HPLC), SDS–PAGE, and infrared spectroscopy were used to monitor BSA degradation. BSA was most stable at pH 7, but rapidly degraded via aggregation and hydrolysis at pH 2. These simulated degradation products were nearly identical to that of unreleased BSA found entrapped within PLGA 50/50 millicylinders. At pH 2, changes in BSA conformation detected by various spectroscopic techniques were consistent with acid denaturation of the protein. By contrast, at pH 5 and above, damage to BSA was insufficient to explain the instability of the protein in the polymer. Thus, these data confirm the hypothesis that acid-induced unfolding is the basis of BSA aggregation in PLGA and the acidic microclimate within PLGA is indeed a dominant stress for encapsulated BSA. To increase the stability of proteins within PLGA systems, formulations must protect against potentially extreme acidification such that native structure is maintained. © 2006 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 95: 1626–1639, 2006 | en_US |
dc.format.extent | 248001 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Chemistry | en_US |
dc.subject.other | Food Science, Agricultural, Medicinal and Pharmaceutical Chemistry | en_US |
dc.title | BSA degradation under acidic conditions: A model for protein instability during release from PLGA delivery systems | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109 | en_US |
dc.contributor.affiliationother | Department of Pharmaceutical Sciences, School of Pharmacy, Center for Pharmaceutical Biotechnology, University of Colorado Health Sciences Center, Denver, Colorado 80262 | en_US |
dc.contributor.affiliationother | Department of Formulation Development, Neose Technologies, Inc., 102 Witmer Road, Horsham, Pennsylvania 19044 | en_US |
dc.contributor.affiliationother | Department of Pharmaceutical Sciences, School of Pharmacy, Center for Pharmaceutical Biotechnology, University of Colorado Health Sciences Center, Denver, Colorado 80262 ; Department of Pharmaceutical Sciences, School of Pharmacy, Center for Pharmaceutical Biotechnology, University of Colorado Health Sciences Center, Denver, Colorado 80262. Telephone: 303-315-6073; Fax: 303-315-0274 | en_US |
dc.identifier.pmid | 16729268 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/55225/1/20625_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/jps.20625 | en_US |
dc.identifier.source | Journal of Pharmaceutical Sciences | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Accessibility: If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.